Bmi1 inhibition enhances the sensitivity of pancreatic cancer cells to gemcitabine.
about
Bmi1 inhibition enhances the sensitivity of pancreatic cancer cells to gemcitabine.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bmi1 inhibition enhances the sensitivity of pancreatic cancer cells to gemcitabine.
@en
Bmi1 inhibition enhances the sensitivity of pancreatic cancer cells to gemcitabine.
@nl
type
label
Bmi1 inhibition enhances the sensitivity of pancreatic cancer cells to gemcitabine.
@en
Bmi1 inhibition enhances the sensitivity of pancreatic cancer cells to gemcitabine.
@nl
prefLabel
Bmi1 inhibition enhances the sensitivity of pancreatic cancer cells to gemcitabine.
@en
Bmi1 inhibition enhances the sensitivity of pancreatic cancer cells to gemcitabine.
@nl
P2093
P2860
P356
P1433
P1476
Bmi1 inhibition enhances the sensitivity of pancreatic cancer cells to gemcitabine.
@en
P2093
Chunyou Wang
Hengqiang Zhao
Pengfei Shi
Qiang Shen
Qingke Duan
Soriba Naby Camara
Zhengle Zhang
P2860
P304
37192-37204
P356
10.18632/ONCOTARGET.9293
P407
P577
2016-05-11T00:00:00Z